Skip to main content
. 2015 Mar 14;6(13):11038–11046. doi: 10.18632/oncotarget.3566

Figure 4.

Figure 4

(A) Differences in time from inoculation to clinical evidence of intraocular tumor growth, (B) tumor growth to death and (C) inoculation to death (survival time) between the PTU (n=8), thyroxine (n=11) and control (n=9) groups. Data are presented as mean ± standard deviation. PTU – propylthiouracil.